ArticleFrontiers in microbiology2026
Bacterial distribution and drug resistance patterns of urinary tract infection in tuberculosis patients: a 5-year retrospective study.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the bacterial distribution and drug resistance profile of urinary tract infections (UTIs) in tuberculosis patients, and to provide evidence-based support for the rational clinical use of antimicrobial agents in this specific patient population. Methods: A retrospective analysis was performed on bacterial identification and antimicrobial susceptibility test results of tuberculosis patients complicated with UTIs in our hospital from January 2020 to December 2024. Data were processed via WHONET 5.6 and SPSS 21.0. Results: A total of 1,151 strains were isolated, including 878 Gram-negative strains (76.3%, mainly Conclusion: Continuous monitoring of bacterial distribution and drug resistance in tuberculosis patients with UTIs is essential to improve diagnosis and treatment accuracy and guide rational clinical medication use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.